Quantitative risk assessment of hepatitis E virus: modelling the occurrence of viraemic pigs and the presence of the virus in organs of food safety interest by Crotta, M et al.
  
RVC OPEN ACCESS REPOSITORY – COPYRIGHT NOTICE 
 
This is the peer-reviewed, manuscript version of an article published in Microbial Risk 
Analysis. The version of record is available from the journal site: 
http://dx.doi.org/10.1016/j.mran.2018.02.001.  
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/. 
The full details of the published version of the article are as follows: 
 
TITLE: Quantitative risk assessment of hepatitis E virus: modelling the occurrence of 
viraemic pigs and the presence of the virus in organs of food safety interest 
AUTHORS: Crotta, M; Lavazza, A; Mateus, A; Guitian, J 
JOURNAL: Microbial Risk Analysis 
PUBLISHER:  Elsevier 
PUBLICATION DATE: 9 February 2018 (online) 
DOI: 10.1016/j.mran.2018.02.001 
1 
 
Quantitative risk assessment of hepatitis E virus: modelling the occurrence of viraemic pigs 
and the presence of the virus in organs of food safety interest. 
Matteo Crottaa1, Antonio Lavazzab, Ana Mateusa, Javier Guitiana 
a Veterinary Epidemiology, Economics and Public Health Group. The Royal Veterinary College. 
Hawkshead Lane. North Mymms. AL9 7TA, Hatfield, UK 
b Istituto Zooprofilattico Sperimentale della Lombardia e dell' Emilia, Brescia, Italy. 
KEYWORDS 
Risk assessment, HEV, foodborne pathogen, zoonotic disease, pork, pigs, transmission model  
 
   Running title 
Modelling the occurrence of hepatitis E virus in organs of slaughter-age pigs  
                                                          
1 Corresponding author: Matteo Crotta. Mail : mcrotta4@rvc.ac.uk 
2 
 
ABSTRACT 
Hepatitis E virus (HEV) is a zoonotic pathogen with consumption of pork and derived products 
identified in different countries as a risk factor for human exposure to HEV. Great efforts have 
been made to understand the dynamics of virus transmission within domestic swine 
populations through modelling.  However, from a food safety prospective, it is critical to 
integrate the parameters involved in the transmission dynamics with those governing the 
actual presence of HEV in the bloodstream, the liver, gallbladder or faeces.  To date, several 
aspects related to the pathogenesis of the disease are still unknown or characterized by 
significant levels of uncertainty, making this conjunction challenging. We used published 
serological data obtained from pigs in a farrow-to-finish farm to implement an Immune-
Susceptible-Infected-Recovered (MSIR) model reproducing the on-farm dynamics that lead to 
the occurrence of viraemic pigs at slaughter. Expert opinion on the length of time infectious 
HEV can be detected in liver, gallbladder/bile and faeces after recovery from viraemic status 
were used to inform a stochastic model aimed at estimating the expected proportion of 
viraemic pigs (𝐻𝐸𝑉𝑉
+), pigs with infectious HEV in liver (𝐻𝐸𝑉𝐿
+), gallbladder/bile (𝐻𝐸𝑉𝐺
+) 
and faeces (𝐻𝐸𝑉𝐹
+) entering the slaughterhouse. To simulate the potential effect of on-farm 
mitigation strategies, we estimated the changes in outcomes of interest as a function of 
variations in the baseline transmission parameters. The model predicted a proportion of 
viraemic pigs entering the slaughterhouse of 13.8% while the proportions of 𝐻𝐸𝑉𝐿
+, 𝐻𝐸𝑉𝐺
+ 
and 𝐻𝐸𝑉𝐹
+ ranged from 13.8% to 94.4%, 13.8% to 94.7% and from 25.3% to 30.8% 
respectively, due to the uncertainty surrounding the experts’ opinions. Variations in MSIR 
model’s parameters alert of the need to carefully consider in the application of mitigation 
strategies aimed at delaying the decay of maternal immunity or the peak of the within herd 
transmission. When the rate of decay of maternal immunity and the transmission rate were 
decreased between 80% and 5% and 40% and 5% from the baseline values respectively, 
adverse effects on 𝐻𝐸𝑉𝑉
+ were observed. The model highlights the relevance of specific 
aspects in the pathogenesis of the disease from a food safety prospective and it was 
developed to be easily reproducible and updatable as soon as accurate data becomes 
available. As presented, the model can be directly connected to existing or future pig-related 
models to estimate the significance of the identified parameters on the risk of human 
exposure to HEV through consumption of pork products.   
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1. INTRODUCTION 1 
The European Food Safety Authority (EFSA) recognises hepatitis E as an emerging public 2 
health concern in Europe with a complex epidemiology that includes foodborne transmission 3 
[1].Hepatitis E virus (HEV) is a non-enveloped positive-stranded RNA virus; four different 4 
genotypes, each including several subtypes, have been identified so far and linked to specific 5 
geographical distributions and host ranges [2]. Genotypes G1 and G2 have been isolated only 6 
in humans and are associated with epidemics in Asia, Africa and Central America [3] whereas 7 
G3 and G4 are zoonotic and circulate in humans and several animals, particularly pigs and 8 
other mammalian species [3-6]. Hepatitis E is usually a mild, self-limiting infection but some 9 
cases may develop into a fulminant form with reported mortality rates ranging from 1 to 4% 10 
and up to 25% in pregnant woman [7]. 11 
A high seroprevalence of zoonotic HEV is reported in pig populations of industrialized 12 
countries [8-12] and HEV RNA has been isolated from processed pork products, especially 13 
those containing liver [13-15]. A recent case-control study associated the consumption of 14 
processed pork products with indigenous HEV infection [16] in England and Wales and several 15 
studies indicated meat products as a source of infection in humans [17-19]. This evidence and 16 
the ubiquitous nature of the virus in animals -particularly in domestic pigs- raises public health 17 
concern for zoonotic infection through direct contact with infected animals or through the 18 
consumption of animal meats. 19 
With particular reference to the risk of infection through consumption of meat products, the 20 
likely impact of HEV on food safety can be quantified adopting a probabilistic approach and 21 
estimating the probability of exposure to the virus through consumption of pork products. 22 
Recently, two quantitative risk assessment (QRA) have been published, both aimed at 23 
estimating the probability of human exposure to HEV through consumption of pork liver and 24 
liver sausages in Switzerland [20, 21].  These models considered the food products rather than 25 
individual pigs as the starting point, therefore, the farm level dynamics describing the 26 
infectious status of the animals entering the slaughterhouse and the events occurring at 27 
processing stage were not explored.  28 
Understanding the role of the dynamics leading to viraemic pigs at slaughter is critical because 29 
the presence of HEV in bloodstream is considered as the plausible vehicle for the zoonotic 30 
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transmission of the virus in humans [22]. Moreover, in prospective of future implementation 31 
of comprehensive ‘farm-to-fork’ QRA, it is important to identify the key biological parameters 32 
governing the presence of HEV not only in pigs’ meat but also in the key offal of major interest 33 
as food products (i.e. liver) or as potential source of cross-contamination at slaughter (i.e. 34 
faeces, intestine or bile). 35 
In recent years, several studies explored and implemented mathematical models to estimate 36 
the transmission parameters of HEV within different domestic swine populations in different 37 
countries [8, 23-25]. These studies were based on field data and represent a valuable 38 
contribution for the understanding of HEV in-field transmission dynamics and the role of 39 
factors influencing the probability of infection (e.g. environmental contamination, maternal 40 
immunity). However, these models were parameterized using longitudinal data obtained 41 
from faecal or serological samples but the actual presence of the virus in the bloodstream and 42 
in key organs of food safety interest were not considered. Furthermore, pathogenesis of 43 
hepatitis E is still poorly understood [26-28], and predicting the presence of the virus in the 44 
internal organs over time is challenging given the scarcity of data from dedicated 45 
experimental studies. 46 
Following these considerations, the objectives of this study were to: (i) implement a baseline 47 
model reproducing the dynamics of HEV infection in a closed population of naturally infected 48 
pigs in a farrow-to-finish farm; (ii) estimate the expected proportion of pigs entering the 49 
slaughterhouse with infected livers, gallbladder/bile, and excreting virus in faeces and, (iii) 50 
quantify the effect of the uncertainty and data gaps in the parameters underlying those 51 
estimations.  52 
2. MATERIAL AND METHODS 53 
2.1. Baseline model 54 
Data reported from the longitudinal study conducted by De Deus et al., [29] were used to 55 
estimate the parameters of a compartmental model describing the viraemic status of a closed 56 
population of pigs over time. 57 
This study was identified as a part of a literature screening conducted in February 2017 on 58 
studies reporting longitudinal data on HEV infection preferably in naturally infected swine 59 
herds. The PubMed search engine of the MEDLINE database was used with the query:   60 
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“(Hepatitis E[Title] AND Longitudinal[Title] AND Pigs[title] OR Hepatitis E[Title] AND Naturally 61 
infected[Title] AND Pigs[title])” and six items were found. Amongst the candidate studies, De 62 
Deus et al. [29], was considered as the most easily reproducible to implement the baseline 63 
model to be used for the purpose of this work.  64 
In that study, 45 piglets from 19 sows from the same weekly farrowing batch were randomly 65 
selected and serially bled at 1, 3, 6, 9, 12, 15, 18 and 22 weeks of age. Serum samples were 66 
tested for specific anti-HEV antibodies by ELISA and the presence of HEV RNA was assessed 67 
by means of a semi-nested RT-PCR. 68 
As the authors reported the proportion of piglets showing evidence of maternal immunity, an 69 
MSIR model (an extension of the Susceptible-Infectious-Recovered (SIR) model that includes 70 
the M class for maternally-derived immunity) was used to describe the transition of the 71 
population among the compartments in time. The observed number of immune and viraemic 72 
pigs in the original study are reported in table 1. 73 
The model is described by the set of ordinary differential equations: 74 
𝑑𝑀
𝑑𝑇
= −𝛿𝑀 75 
𝑑𝑁𝑣
𝑑𝑇
= 𝛿𝑀 − 𝛽𝑁𝑣𝑉 76 
𝑑𝑉
𝑑𝑇
= 𝛽𝑁𝑣𝑉 − 𝛾𝑉 77 
𝑑𝑅
𝑑𝑇
= 𝛾𝑉 78 
Where: δ is the decay rate of the population with maternal immunity (M), β is the transition 79 
rate from Not-viraemic (Nv) to viraemic (V) and γ represents the recovery rate from the 80 
viraemic status. 81 
The 45 monitored piglets were sampled from a number of sows representing 8% of the total 82 
sow population (total number of sows in the farm = 240). The hypergeometric process was 83 
used to estimate at each ith sampling time the most likely number of seropositive or infected 84 
animals if the same proportion of piglets were sampled from the overall sow population. 85 
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The estimated proportions of seropositive and infected pigs at each sampling point were used 86 
to estimate the rates of decay of animals with maternal immunity (δ), of infection (β) and of 87 
recovery (γ). The system of differential equations was first informed by tentative values for 88 
the unknown parameters and the reduced gradient algorithm (GRG) for nonlinear problems 89 
was then used to estimate the set of parameters that minimizes the residuals from observed 90 
and predicted values. A convergence tolerance of 0.0001 was selected as the acceptable 91 
relative change in the absolute value of the target (difference in residuals) indicating the 92 
objective function value is changing very slowly as algorithm progresses from point to point.  93 
The parameterized system of differential equations allows to estimate the number of 94 
immune, not-viraemic, infected and recovered animals at any point in time, therefore, it was 95 
used to obtain the proportions of interest at the day of depopulation (dpDay) when animals 96 
are sent to the slaughterhouse (consistent to De Deus et al., dpDay was set to 154). 97 
2.2. Infectious status of the pigs in the different compartments. 98 
The status of individual pigs at dpDay was used to infer the expected proportions of viraemic 99 
animals (𝐻𝐸𝑉𝑉
+), animals with infected livers (𝐻𝐸𝑉𝐿
+), gallbladder/bile (𝐻𝐸𝑉𝐺
+) and 100 
animals excreting virus in their faeces (𝐻𝐸𝑉𝐹
+). To this end, the following evidence and 101 
assumptions about not-viraemic, viraemic and recovered animals were combined: 102 
(i) Not-viraemic. Animals belonging to this category are not in the viraemic phase and 103 
specific anti HEV antibodies are not present. In not-viraemic animals, the presence of the virus 104 
in faeces cannot be excluded. In fact, extra-hepatic sites of virus replication have been  105 
identified [30] and it is possible that the virus replicates in the intestinal tract before reaching 106 
the liver. The presence of genomic HEV RNA in faeces has been reported from a number of 107 
days before the onset of viremia ranging from: 10-60 [31], 7-28 [32], and 8.3-17 days [22].  108 
In the model it is assumed that the not yet infected animals are excreting the virus with faeces 109 
from a minimum of 7 to a maximum of 60 days before the onset of the viraemic phase. The 110 
uncertainty in this length of time (𝑁𝑣𝐹
+) is described by the rounded Uniform distribution: 111 
𝑁𝑣𝐹
+ = 𝑈𝑛𝑖𝑓𝑜𝑟𝑚(7; 60) 𝑑𝑎𝑦𝑠  112 
In the model, the overall proportion of not-viraemic animals excreting HEV RNA with faeces 113 
(𝐻𝐸𝑉𝑁𝑣
𝐹+
) at dpDay is equal to the proportion of not-viraemic animals which is predicted to 114 
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become infected from dpDay to dpDay + 𝑁𝑣𝐹
+ (i.e. the animals are assumed to have the virus 115 
detectable in faeces at least 𝑁𝑣𝐹
+ days before onset of viremia).  116 
(ii) Viraemic. In these animals, the virus is detectable in the bloodstream. It is assumed 117 
that in viraemic animals the liver and the organs, where the virus is known to accumulate and 118 
replicate, are infected. Viraemic pigs are also assumed to actively excrete virus with faeces 119 
during this stage. 120 
(iii) Recovered. Animals belonging to this category recovered from viraemia and anti-HEV 121 
IgG are detectable in the bloodstream. Genomic HEV RNA might still be detectable in the  122 
faeces and key internal organs such as liver, bile and intestine [33]. 123 
The length of time during which the virus can be detected in the liver and target organs in 124 
animals recovered from viraemia, and whether the virus is present in its infective form in 125 
these animals is unknown. Some indication of virus persistence is shown from results of an 126 
experimental study conducted in Italy where HEV RNA was detected in the liver of one pig 127 
that had recovered from viremia 7 days before [34]. However, as the pig was sacrificed, it was 128 
not possible to estimate for how long the virus could have remained present in liver after 129 
recovery from viremia. In the study by De Deus et al. [29], HEV RNA was observed in the livers 130 
and faeces of two non-viraemic pigs but unfortunately from reported results, it is not possible 131 
to ascertain whether the same animals had been viraemic previously. Furthermore, it cannot 132 
be ruled out that the presence of the virus in the liver of these animals simply indicated the 133 
pre-viraemic phase.  134 
2.3. Expert opinion 135 
In the model, the expected length of time the virus is still detectable in liver (𝑅𝐿
+) and 136 
gallbladder/bile (𝑅𝐺
+) after recovery from viraemia were obtained by expert opinion.  137 
Ten international experts agreed to provide their opinion about the minimum (MIN) and 138 
maximum (MAX) value of the delta time period elapsing from the resolution of viraemic phase 139 
to the absence of infectious HEV from the liver and gallbladder/bile. For each estimation, 140 
interviewees were also asked to give a score on a scale from 1 (not confident) to 4 (confident) 141 
to describe how confident they were with their own estimations. 142 
Results were included into a discrete distribution: 143 
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𝑅𝐿
+, 𝑅𝐺
+ =  𝐷𝑖𝑠𝑐𝑟𝑒𝑡𝑒({𝑥𝑖}; {𝑝𝑖}) 𝑑𝑎𝑦𝑠 144 
where  {𝑥𝑖} is the vector of the ranges modelled as rounded Uniform distributions (with the 145 
Minimum and Maximum values identified by each ith expert being the distribution’s 146 
parameters) and {𝑝𝑖} is the vector of the weights given to each opinion. This way, each 147 
expert’s distribution has a chance to be sampled proportional to its level of confidence.  148 
The expected proportion of recovered animals excreting the virus with faeces (𝐻𝐸𝑉𝑅
𝐹+
) was 149 
estimated assuming that infectious HEV remains detectible in faeces at least for a length of 150 
time (𝑅𝐹
+) ranging from 14 to 21 days after recovery from viraemia [32, 35]. Again, a discrete 151 
uniform distribution was used to assume that every number of days within the range 14-21 is 152 
equally probable. 153 
All the proportions of recovered animals with virus present in the liver (𝐻𝐸𝑉𝑅
𝐿+
), 154 
gallbladder/bile (𝐻𝐸𝑉𝑅
𝐺+
) and faeces (𝐻𝐸𝑉𝑅
𝐹+
) were obtained from the calculated 155 
proportions of recovered animals on day: (𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐿
+), (𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐺
+) and (𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐹
+) 156 
respectively.  157 
Finally, the overall proportions of viraemic animals (𝐻𝐸𝑉𝑉
+), animals with infected 158 
livers (𝐻𝐸𝑉𝐿
+), animals with infected gallbladder/bile (𝐻𝐸𝑉𝐺
+) and animals actively 159 
excreting HEV with faeces (𝐻𝐸𝑉𝐹
+) were estimated as: 160 
𝐻𝐸𝑉𝑉
+ = 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓 𝑣𝑖𝑟𝑎𝑒𝑚𝑖𝑐 𝑎𝑡 𝑑𝑝𝐷𝑎𝑦 161 
𝐻𝐸𝑉𝐿
+ = 𝐻𝐸𝑉𝑉
+ + 𝐻𝐸𝑉𝑅
𝐿+
 162 
𝐻𝐸𝑉𝐺
+ = 𝐻𝐸𝑉𝑉
+ + 𝐻𝐸𝑉𝑅
𝐺+
 163 
𝐻𝐸𝑉𝐹
+ = 𝐻𝐸𝑉𝑉
+
+ 𝐻𝐸𝑉𝑁𝑣
𝐹+
+  𝐻𝐸𝑉𝑅
𝐹+
 164 
All the outcomes of the model were obtained by means of Monte Carlo simulation (500,000 165 
iterations). The risk analysis software @Risk (version 7.0.1 for Excel, Palisade Corporation, 166 
Newfield, NY) was used for the simulations and the sensitivity analysis. Statistical software R 167 
3.3.0 was used for the graphical display of results. The inputs and expected outcomes of the 168 
baseline model are presented in table 2. 169 
2.4.  Assessment of the uncertainty and variability in model inputs  170 
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All the estimations for the parameters of interest (𝐻𝐸𝑉𝑉
+, 𝐻𝐸𝑉𝐿
+, 𝐻𝐸𝑉𝐺
+ and 𝐻𝐸𝑉𝐹
+) 171 
obtained in the baseline model, are strictly dependent upon the uncertainty distributions 172 
describing 𝑁𝑣𝐹
+, 𝑅𝐿
+, 𝑅𝐺
+, 𝑅𝐹
+, the value of dpDay and the parameters of the differential 173 
equations describing transitions across population compartments over time. 174 
In order to quantify the impact of the uncertainty in 𝑁𝑣𝐹
+, 𝑅𝐿
+, 𝑅𝐺
+ and 𝑅𝐹
+, the results of two 175 
scenarios were compared; ‘Scenario A’, with the distribution describing 𝑁𝑣𝐹
+, 𝑅𝐿
+, 𝑅𝐺
+ and 𝑅𝐹
+, 176 
fixed to the value corresponding to their 5th percentile and ‘Scenario B’ where the 177 
distributions were fixed to the value corresponding to the 95th percentile. In addition, as a 178 
sensitivity analysis for the experts’ estimates, all the relevant outputs were calculated 179 
removing the opinions related to the lower level of confidence (i.e. “not confident”). 180 
With respect to δ and β, those parameters are assumed to intrinsically incorporate all the 181 
biological and managerial factors affecting the decay rate in the proportion of animals 182 
covered by maternal immunity and those facilitating or preventing the transmission of HEV 183 
within animals. As indicated by several studies, these parameters are likely to be influenced 184 
by environmental and husbandry practices [23, 29, 36, 37]; however, accurate estimations of 185 
the effects of different management and environmental practices on the model’s parameters 186 
are currently not available. Therefore, a number of arbitrary combinations were explored and 187 
the behaviour of the main model’s outcome (i.e. 𝐻𝐸𝑉𝑉
+) as a function of deviations of ± 100% 188 
(by 5%) in both δ and β was assessed by calculating the outcome for each ith combination. 189 
To this end, two discrete distributions including all the percentage deviations to be explored 190 
were used to calculate the new δ and β at each iteration as follow: 191 
𝛿𝑛𝑒𝑤 = 𝛿 + (𝛿 ∗ ∆(𝛿)) 192 
𝛽𝑛𝑒𝑤 = 𝛽 + (𝛽 ∗ ∆(𝛽)) 193 
∆(𝛿) and ∆(𝛽) are the two equal discrete distributions: 𝐷𝑖𝑠𝑐𝑟𝑒𝑡𝑒(−1, −0.95, … , +0.95, +1) 194 
that were used to modulate the changes in the original parameters during simulations. 195 
Additionally, as the maternal antibodies are transmitted to piglets through colostrum of 196 
seropositive sows, the number of piglets protected by maternal immunity can be reasonably 197 
assumed to be directly dependent on the number of seropositive sows and the cross-fostering 198 
rate at farrowing. In order to test the impact of mitigation strategies aimed at reducing the 199 
number of piglets covered by maternal immunity, 5 scenarios in which the baseline number 200 
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of immune animals (M) is decreased by (5%, 10%, 50%, 90%, 100%) and increased by (5%, 201 
10%, 45%) were simulated.   202 
3. RESULTS 203 
3.1. Baseline model 204 
The parameters of the differential equations maximizing the chances of obtaining the 205 
observed values are reported in table 2. Figure 1 provides a graphical representation 206 
comparing the predicted dynamics with the data observed by De Deus et al. [29]. 207 
Our model predicted a proportion of 13.8% viraemic pigs at depopulation, which is consistent 208 
with the proportion observed by De Deus et al. [29] (i.e. 12.5%). 209 
The results of different scenarios implemented to evaluate the effects on 𝐻𝐸𝑉𝑉
+ of 210 
hypothetical interventions aimed at increasing/reducing the infection rate or the decay of 211 
maternal immunity are summarized in figure 2.  212 
When β was kept to its baseline value, a reduction in δ equal to a value between 0.05% and 213 
80.0% of its baseline value led to an increased proportion of viraemic pigs entering the 214 
slaughterhouse. Similarly, reducing β by an amount between 0.05% and 40.0% of its baseline 215 
value would lead to an increase in 𝐻𝐸𝑉𝑉
+at dpDay. In both cases, an increase in the baseline 216 
value of δ and β would generate a lower proportion of viraemic pigs at the end of the 217 
production cycle.  218 
A similar effect was observed, when δ and β were kept constant and the effect of changes in 219 
the number of piglets covered by maternal immunity at t0 was assessed (Figure 3). 220 
Results indicated that for example, a 10% reduction in the number of piglets acquiring 221 
antibodies from colostrum would lead to a decrease in the prevalence of infected pigs at 222 
slaughter equal to ~8% of the baseline (12.5%). On the other hand, if all the pigs were covered 223 
by maternal immunity at t0 (+45% of the baseline which is equal to the whole population of 224 
560 pigs) the simulated proportion of viraemic pigs at slaughter would be expected to increase 225 
to 19.8%.  226 
3.2. Expert opinion results 227 
Results of questionnaires submitted to experts investigating the persistency of infectious HEV 228 
in liver and gallbladder/bile from animals recovered from the viraemic phase are reported as 229 
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violin plots in figure 4. The violin plot describing the uncertainty in the number of days 230 
infectious HEV remains detectable in livers of animals recovered from viremia  𝑅𝐿
+ ranged 231 
from 0 to 120 days with a median value of 11 and 7, 23 and 51 at 25th, 75th and 95th percentile 232 
respectively. The violin plot describing the uncertainty in the number of days infectious HEV 233 
remains detectable in gallbladder/bile of animals recovered from viremia  𝑅𝐺
+ ranged from 0 234 
to 180 days with a median value of 23 and 7, 40 and 83 at 25th, 75th and 95th percentile 235 
respectively. When the experts’ estimates corresponding to the lower level of confidence 236 
were removed, the new distribution for 𝑅𝐿
+, (𝑅𝐿𝑐
+ ) ranged from 0 to 45 with median value of 237 
8 and 6, 8 and 22 at 25th, 75th and 95th percentile. Similarly, the new distribution for 𝑅𝐺
+, (𝑅𝐺𝑐
+ ) 238 
ranged from 0 to 60 with median value of 14 and 7, 14 and 37 at the 25th, 75th and 95th 239 
percentile respectively. 240 
3.3. Predicted proportion of 𝑯𝑬𝑽𝑳
+, 𝑯𝑬𝑽𝑮
+ and 𝑯𝑬𝑽𝑭
+. 241 
The probability of a random pig excreting infectious HEV with faeces at depopulation ranged 242 
from 25.3% to 30.8% with a median value of 27.5% and 26.8% and 29.1% at 25th and 75th 243 
percentile. The probability of a random pig entering the slaughterhouse with infectious HEV 244 
in liver ranged from 13.8% to 94.4% with a median value of 20.0% and 17.5% and 32.9% at 245 
25th and 75th percentile. Finally, the probability of infectious HEV in gallbladder/bile ranged 246 
from 13.8% to 94.7% with a median value of 29.2% and 17.5% and 47.2% at 25th and 75th 247 
percentile respectively. Particularly for 𝐻𝐸𝑉𝐿
+ and 𝐻𝐸𝑉𝐺
+, as these probabilities were totally 248 
dependent upon 𝑅𝐿
+ and 𝑅𝐺
+, the shapes of their distributions were compatible with the 249 
results obtained from the expert opinion (Figure 4). 250 
3.4. Sensitivity analysis 251 
The predicted proportions animals with infected liver (𝐻𝐸𝑉𝐿
+) and gallbladder/bile (𝐻𝐸𝑉𝐺
+) 252 
at 𝑑𝑝𝐷𝑎𝑦  when answers with a low level of confidence were removed (i.e. 𝑅𝐿𝑐
+  and 𝑅𝐺𝑐
+  are 253 
used during simulation) are reported in table 4. The less confident experts were also those 254 
providing the higher upper limits in the individual discrete distributions describing both 𝑅𝐿
+ 255 
and 𝑅𝐺
+; Removing their estimations generated remarkable differences in the distributions’ 256 
(right) tails while the values at 25th, 50th and 75th percentiles remained compatible with the 257 
baseline.  258 
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When all the uncertainty distributions describing 𝑁𝑣𝐹
+, 𝑅𝐿
+, 𝑅𝐺
+ and 𝑅𝐹
+ were fixed to the 5th 259 
percentile (i.e. Scenario A),  𝐻𝐸𝑉𝐿
+ and 𝐻𝐸𝑉𝐺
+ resulted 13.8%, the same value as 𝐻𝐸𝑉𝑉
+, 260 
this is because the 5th percentile of both 𝑅𝐿
+, 𝑅𝐺
+ is 0, while 𝐻𝐸𝑉𝐹
+ resulted 25.3%. When the 261 
values at 95th percentile were used (i.e. Scenario B) 𝐻𝐸𝑉𝐿
+, 𝐻𝐸𝑉𝐺
+and 𝐻𝐸𝑉𝐹
+resulted 262 
63.8%, 90.05% and 30.8% respectively. Those results indicate a relevant effect of the 263 
uncertainty in those parameters. 264 
4. Discussion 265 
We used observed longitudinal data on hepatitis E infection in a closed pig population to 266 
adapt a MSIR model in order to reproduce and explore the dynamics leading to animals 267 
carrying HEV entering the slaughterhouse. 268 
In recent years, several studies aimed at estimating the transmission parameters of HEV in 269 
pigs have been published [8, 23, 24]. It should be considered that the main objective of this 270 
study was to assess the practical consequences of variations in the model parameters rather 271 
than to provide an improved method for model parameterization. For this reason, the simple 272 
method we used to obtain the best parameter estimates was considered adequate for the 273 
scope of this study. When the parameters of the model were modified to simulate the effects 274 
of hypothetical strategies that could modify the rates at which maternal immunity declines 275 
or pig-to-pig transmission occurs; undesirable effects (i.e. delay in the prevalence peak 276 
leading to more viraemic pigs at depopulation) were observed suggesting great caution when 277 
considering such measures.  278 
Only extreme scenarios where the rate of decay of maternal immunity was 80% lower than 279 
the baseline and the infection rate 40% lower led to a reduction in the predicted proportion 280 
of viraemic pigs at slaughterhouse (Figure 2). Smaller reductions would have the opposite 281 
effect on the infectious fraction at slaughter age. This is due to the fact is that animals would 282 
be infected at a later age and the prevalence peak would consequently shift towards the 283 
slaughter age as already observed by Backer at al. [24]. For the same reason, paradoxically, 284 
the behaviour of the model in response to changes in both parameters indicated that if a 285 
given ‘threshold’ reduction is not achieved, the positive effect can be observed by decreasing 286 
the infection age so that prevalence peaks earlier. The same logic applies when changing the 287 
proportion of piglets covered by maternal immunity at t0 (figure 3). It should be considered 288 
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that both the parameters related to number of piglets covered by maternal immunity at t0 289 
and the rate of decay of maternal immunity are strictly related to the infectious status of the 290 
sows (and previous exposure to HEV) and the management of the piglets. In fact, the presence 291 
of anti-HEV antibodies in the colostrum is conditional to the seropositive status of the sow 292 
and the serological titres of piglets at one week of age was found to be highly correlated with 293 
those of the dams [37]. This evidence suggests that the decay of the maternal immunity at 294 
individual level (and thus in the population), is also strictly related to the amount of antibodies 295 
each piglet acquired through colostrum ingestion. Furthermore, cross-fostering rate at 296 
farrowing has been found to be a significant risk factor for the presence of viraemic pigs at 297 
slaughter [38]. All the available evidence indicate that mitigation strategies aimed at reducing 298 
the number of seropositive sows at farrowing could lead to an overall decrease in the number 299 
of viraemic pigs entering the slaughterhouse.  300 
 To our knowledge, this is the first attempt at exploring HEV dynamics considering the 301 
persistence of infectious HEV in animals recovered from the viraemic phase. This feature is of 302 
critical importance in terms of the public health implications of HEV infection in slaughter pigs 303 
and essential for any future probabilistic assessment of human HEV exposure through the 304 
consumption of pork products. In fact, on one hand, some of those organs are food product 305 
themselves and the consumption of products containing pork liver has been identified as risk 306 
factor for human HEV infection [13, 15, 39, 40]. Furthermore, the presence of active virus in 307 
this organ, in bile and in faeces, might lead to cross-contamination during the evisceration 308 
procedures at the slaughterhouse where the rupture of the guts or gallbladder may occur. 309 
In this study, we made use of the ‘expert opinion’ to overcome the lack of data/evidence on 310 
key aspects of the hepatitis E pathogenesis. 311 
Although the estimations we obtained for the parameters 𝑅𝐿
+ and 𝑅𝐺
+ are characterized by 312 
considerable uncertainty (reflecting the actual lack of knowledge in this key aspect of HEV 313 
pathogenesis), this approach gave us the opportunity to assess the extent of this key data gap 314 
and the importance of the uncertainty surrounding those parameters from a food safety 315 
prospective. Lack of data against with this results can be compared (i.e. longitudinal data 316 
including the proportions of recovered pigs with infected livers and gallbladders at 317 
depopulation) prevented a proper validation of the model outcomes. Generating knowledge 318 
to fill the identified gaps might be challenging, but essential in order to conduct a sound 319 
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quantitative assessment of exposure to HEV through consumption of pork meat or products 320 
made with pork meat. 321 
Main assumptions 322 
Consistently with available evidence [31, 32] and the above referenced studies estimating the 323 
rate of HEV transmission by means of SIR models, the main assumptions made in the structure 324 
of the model are: (i) homogeneous mixing of the pigs within the herd and (ii) no reversion 325 
back to the viraemic stage once immunity is developed.  326 
Conclusions 327 
We developed a stochastic model suitable to estimate the expected proportions of pigs 328 
carrying hepatitis E virus in their blood, liver, gallbladder/bile and faeces when entering the 329 
slaughterhouse. Thus, the model extends previous simulation frameworks that were 330 
restricted to viraemic animals to include all groups of animals of relevance from a food safety 331 
perspective. Although considerable uncertainty exists regarding key parameters of the model, 332 
it allows a critical evaluation of the potential consequences of on-farm mitigation strategies 333 
and a quantification of the impact of the most important gaps in knowledge in the 334 
pathogenesis of HEV.  335 
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TABLES 425 
Table 1. Observed number of pigs with evidence of maternal derived immunity (M) and 426 
viraemia (V) in time as reported by De Deus et al., [29].  427 
sampling 
week 
Sample size M (𝐻𝐸𝑉 𝐼𝑔𝐺+) I (𝐻𝐸𝑉𝑉
+) 
1 42 23 3 
3 43 15 3 
6 41 9 1 
9 36 5 4 
12 30 Na 7 
15 26 Na 11 
18 21 Na 5 
22 16 Na 2 
 428 
Table 2. Overview of the model inputs and expected outcomes of the baseline model. 429 
Input Distribution/Function Description Unit Source 
dpDay Constant Day of depopulation Day  [29] 
𝐻𝐸𝑉𝑉
+ Infected at dpDay 
Predicted proportion of viraemic 
animals at dpDay 
% // 
𝑁𝑣𝐹
+ Uniform (7;60) 
Number of days Not-viraemic 
animals are excreting HEV with 
faeces before onset of viraemia 
Days [31, 32] 
𝑅𝐿
+ 𝐷𝑖𝑠𝑐𝑟𝑒𝑡𝑒({𝑥𝑖}; {𝑝𝑖} 
Number of days infectious HEV 
remains detectable in livers of 
animals recovered from viraemia 
Days  
Expert 
opinion 
𝑅𝐺
+ 𝐷𝑖𝑠𝑐𝑟𝑒𝑡𝑒({𝑥𝑖}; {𝑝𝑖} 
Number of days infectious HEV 
RNA remains detectable in 
gallbladder of animals recovered 
from viraemia 
Days 
Expert 
opinion 
𝑅𝐹
+ 𝐷𝑖𝑠𝑐𝑟𝑒𝑡𝑒(14, . . ,21; 1, . . ,1) 
Number of days HEV RNA 
remains detectable in faeces of 
animals recovered from viraemia 
Days  [31, 32] 
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𝐻𝐸𝑉𝑁𝑣
𝐹+
 (𝐻𝐸𝑉𝑉
+𝑎𝑡 𝑑𝑝𝐷𝑎𝑦 + 𝑁𝑣𝐹
+) 
Predicted proportion of Not-
viraemic animals excreting HEV 
with faeces at 𝑑𝑝𝐷𝑎𝑦 + 𝑁𝑣𝐹
+  
% // 
𝐻𝐸𝑉𝑅
𝐿+
 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 𝑎𝑡: 𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐿
+ 
Proportion of recovered animals 
with infected liver 
% // 
𝐻𝐸𝑉𝑅
𝐺+
 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 𝑎𝑡: 𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐺
+ 
Proportion of recovered animals 
with infected gallbladder/bile 
% // 
𝐻𝐸𝑉𝑅
𝐹+
 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑 𝑎𝑡: 𝑑𝑝𝐷𝑎𝑦 − 𝑅𝐹
+ 
Proportion of recovered animals 
excreting HEV with faeces 
% // 
𝐻𝐸𝑉𝐿
+ 𝐻𝐸𝑉𝑉
+ + 𝐻𝐸𝑉𝑅
𝐿+
 
Overall proportion of animals 
with infected liver at dpDay 
% // 
𝐻𝐸𝑉𝐺
+ 𝐻𝐸𝑉𝑉
+ + 𝐻𝐸𝑉𝑅
𝐺+
 
Overall proportion of animals 
with infected gallbladder/bile at 
dpDay 
% // 
𝐻𝐸𝑉𝐹
+ 𝐻𝐸𝑉𝑉
+ + 𝐻𝐸𝑉𝑁𝑣
𝐹+
+ 𝐻𝐸𝑉𝑅
𝐹+
 
Overall proportion of animals 
excreting HEV with faeces at 
dpDay 
% // 
 430 
Table 3. Estimates of transmission parameters (𝛿 = rate of decay of maternal immunity,  431 
𝛽 = infection rate, 𝛾 = recovery rate) for a MSIR model of hepatitis E transmission, obtained 432 
using the Generalized Reduced Gradient (GRG) algorithm to fit the data from De Deus et al. 433 
[29]. 434 
Parameter Value 
𝛿 3.1E-02 
𝛽 2.5E-04 
𝛾 3.5E-02 
M (t0) 384 
S (t0) 175 
I (t0) 1 
 435 
20 
 
Table 4. Predicted proportions of viraemic animals (𝐻𝐸𝑉𝑉
+), animals with infected 436 
liver (𝐻𝐸𝑉𝐿
+), gallbladder/bile (𝐻𝐸𝑉𝐺
+) and animals actively excreting HEV with faeces 437 
(𝐻𝐸𝑉𝐹
+) at 𝑑𝑝𝐷𝑎𝑦 in the baseline model (baseline) and when opinions from experts with a 438 
level of confidence equal to 1 were removed (s). The values representing the median, 25th and 439 
75th percentiles of the outputs’ distributions are reported together with the Minimum and 440 
Maximum. 441 
 Median Min 25th percentile 75th percentile Max 
𝐻𝐸𝑉𝐿
+(Baseline) 20.0% 13.8% 17.5% 32.9% 94.4% 
𝐻𝐸𝑉𝐺
+(Baseline) 29.2% 13.8% 17.5% 47.2% 94.7% 
𝐻𝐸𝑉𝐹
+(Baseline) 27.5% 25.3% 26.8% 29.1% 30.8% 
𝐻𝐸𝑉𝐿
+(s) 18.1% 13.8% 16.9% 28.3% 53.5% 
𝐻𝐸𝑉𝐺
+ (s) 26,6% 13.8% 17.5% 43.6% 72.4% 
 442 
  443 
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Figure 1 comparison between the population dynamics after parameterization of the set of differential equation describing a MSIR model 444 
and observed data reported by De Deus et al. (2008). Solid grey = covered by passive immunity (M), short dash = Not-viraemic (Nv), solid 445 
black = infected (I), long dash = Recovered (R). Solid circle and triangles are the proportions of animals with maternal immunity and infected 446 
observed by De Deus et al. (2008).  447 
 448 
Figure 2 results of simulated scenarios assessing the behaviour of 𝐻𝐸𝑉𝑉
+as a function of the rate of decay of animals covered by maternal 449 
antibodies (δ) and the infection rate (β). In the upper graph, β was kept constant and equal to the value used in the baseline model and only 450 
variation in δ was assessed. In the lower graph, δ was kept constant and the effects of variation in β were explored. In both the graphs, the 451 
crossed points indicate the percentage variations in δ and β leading to an increased proportion of viraemic pigs at slaughter compared to the 452 
baseline. 453 
 454 
  455 
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Figure 3 graphical representation of changes in baseline proportion of viraemic pigs entering the slaughterhouse when the baseline number 456 
of piglets covered by maternal immunity at t0 decreased by 5%, 10% and 50% or increased by 5%, 10% and 45% from the baseline value. 457 
  458 
Figure 4 Violin plots representing the uncertainty in the length of time infectious HEV can be considered detectable in liver (𝑅𝐿
+) and 459 
gallbladder/bile (𝑅𝐺
+) after recovery from the viraemic phase. For each ‘violin’, the white dot and thick internal lines represent the median 460 
and 25th/75th percentiles, while the total height of the violin represents the range of the data 461 
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